Lower serum CA125 level, negative vascular invasion, and wild BRAF were strongly associated with better 2-year disease-free survival in patients with stage III colorectal cancer who received adjuvant chemotherapy
Author:
Affiliation:
1. Department of Oncology, Affiliated Hospital of Jiangnan University, Wuxi 214062, Jiangsu, China
2. Department of Pathology, Affiliated Hospital of Jiangnan University, Wuxi 214062, Jiangsu, China
Publisher
IOS Press
Subject
Cancer Research,Genetics,Oncology,General Medicine
Reference30 articles.
1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016
2. Adjuvant therapy in colon cancer;Lombardi;Oncology,2009
3. Adjuvant fluorouracil, leucovorin, and oxaliplatin in stage II to III colon cancer: Updated 10-year survival and outcomes according to BRAF mutation and mismatch repair status of the MOSAIC study;André;J Clin Oncol,2015
4. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;André;N Engl J Med,2004
5. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer;Benson;J Clin Oncol,2004
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinicopathologic characteristics and prognosis of synchronous colorectal cancer: a retrospective study;BMC Gastroenterology;2022-03-13
2. Pretreatment Inflammatory Markers Predict Outcomes and Prognosis in Colorectal Cancer Patients With Synchronous Liver Metastasis;Clinical Medicine Insights: Oncology;2022-01
3. Association Between Chemotherapy and Survival in T1 Colon Cancer With Lymph Node Metastasis: A Propensity-Score Matched Analysis;Frontiers in Oncology;2021-07-30
4. MULTIPLEX DETECTION OF TUMOR MARKERS FOR DIFFERENT STAGES OF COLORECTAL CANCER;Siberian journal of oncology;2021-05-02
5. CA125 and CA242 markers’ role in colorectal cancer diagnosis and management – a 30 year review;Romanian Biotechnological Letters;2020-09-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3